Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.

Shares of Marinus Pharmaceuticals, Inc. MRNS fell sharply in today’s pre-market trading after the company issued an update on the Phase 3 RAISE Trial and reported preliminary first quarter 2024 financial results.

Marinus Pharma reported Prelim ZTALMY (Ganaxolone) net product revenue of $7.4 million to $7.6 million for the first quarter.

Marinus Pharmaceuticals shares dipped 74.2% to $1.94in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

  • Neumora Therapeutics, Inc. NMRA shares declined 17.1% to $11.25 pre-market trading after the FDA placed a clinical hold on the company's Phase 1 NMRA-266 study.
  • Roadzen, Inc. RDZN shares fell 14% to $5.04 in pre-market trading.
  • Ultragenyx Pharmaceutical Inc. RARE shares fell 11.4% to $41.64 in pre-market trading after the company disclosed interim Phase 1/2 data in patients with angelman syndrome after treatment with GTX-102.
  • Cogent Biosciences, Inc. COGT shares declined 7.7% to $6.01 in pre-market trading. Cogent Biosciences recently reported preclinical data from CNS-Penetrant ErbB2 Inhibitor Program.
  • Polestar Automotive Holding UK PLC PSNY shares fell 7.2% to $1.35 in pre-market trading.
  • Molina Healthcare, Inc. MOH shares fell 7.1% to $350.00 in pre-market trading.
  • TORM plc TRMD shares slipped 3.1% to $32.92 in pre-market trading.

 

Now Read This: Top 3 Tech Stocks That May Explode This Month

Don’t forget to check out our premarket coverage here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading Ideasbig losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!